Custom crystal celebrating the closing of a tech-focused fund by CVC Capital Partners. The private equity firm is based in London.
(9ACJ257)
Custom crystal celebrating the closing of a tech-focused fund by CVC Capital Partners. The private equity firm is based in London.
(9ACJ257)Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau.
(20ALJ071)Custom Lucite tombstone celebrating the closing of a software-focused fund by Boston-based venture capital firm Elephant Partners.
(20AKL286)Custom deal toy commemorating the launch of CECYLSS, a Japanese joint venture involving NGK Spark Plug and Mitsubishi Hitachi Power Systems.
(20AKL064)Crystal deal toy, featuring a 3D laser-etch of lungs, commemorating a drug commercialization agreement in Japan. The collaboaration between biotherapeutics firm aTyr Pharma and Kyorin Pharmaceutical centers on a treatment for lung diseases.
(20ALJ110)Custom crystal commemorating a joint venture between Rockwell Automation and Schlumberger. The collaboration centers on digitally enabled oilfield automation services.
(20ACJ054)Crystal deal toy commemorating the acquisition of Australia’s CF Asia Pacific, which leases trains and offers rolling stock to rail operators.
(20ALJ067)The DreamWorks IPO deal toy design shouldn’t have been too surprising. Even now, almost 20...
Crystal tombstone commemorating an exclusive licensing agreement between Ovid Therapuetics and Angelini Pharma. The agreement centers on the development, manufacturing, and commercialization of a potential treatment for Angelman syndrome.
(20AJH130)
